Estonia - estonio - Ravimiamet

demo s.a. - tseftasidiim - süste-/infusioonilahuse pulber - 2000mg 1tk

Estonia - estonio - Ravimiamet

pharmaswiss ceska republika s.r.o. - diosmiin - õhukese polümeerikattega tablett - 1000mg 30tk; 1000mg 60tk

Estonia - estonio - Ravimiamet

demo s.a. - tseftasidiim - süste-/infusioonilahuse pulber - 1000mg 1tk

Estonia - estonio - Ravimiamet

boehringer ingelheim animal health france - fiproniil - täpilahus - 268mg 2.68ml 2.68ml 3tk; 268mg 2.68ml 2.68ml 1tk

Estonia - estonio - Ravimiamet

boehringer ingelheim animal health france - fiproniil - täpilahus - 402mg 4.02ml 4.02ml 3tk; 402mg 4.02ml 4.02ml 1tk

Estonia - estonio - Ravimiamet

boehringer ingelheim animal health france - fiproniil - täpilahus - 134mg 1.34ml 1.34ml 3tk; 134mg 1.34ml 1.34ml 1tk

Estonia - estonio - Ravimiamet

boehringer ingelheim animal health france - fiproniil - täpilahus - 67mg 0.67ml 0.67ml 3tk; 67mg 0.67ml 0.67ml 1tk

Unión Europea - estonio - EMA (European Medicines Agency)

accord healthcare s.l.u. - degarelix acetate - eesnäärmevähk - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Estonia - estonio - Ravimiamet

vetviva richter gmbh - buprenorfiin - süstelahus - 0,3mg 1ml 10ml 10tk; 0,3mg 1ml 10ml 1tk; 0,3mg 1ml 10ml 5tk

Estonia - estonio - Ravimiamet

baxalta innovations gmbh - viii hüübimisfaktor - süstelahuse pulber ja lahusti - 500rÜ 5ml 5ml 1viaal